Surgical Innovation Mesh for Cosmetic Surgery Cleared

FDA has cleared a Surgical Innovation Associates 510(k) for DuraSorb Monofilament Mesh, a line of bioabsorbable technologies for reconstructive and cosmetic surgery. “Much like an absorbable stitch, DuraSorb Monofilament Mesh is designed to integrate into the patient’s tissue – providing strong support during the critical initial phases of healing – and then slowly dissolve, leaving the patient free from foreign material within one year,” the company says. “The device brings cutting-edge polymer science and evidence-based engineering to bear on a material that has been safely used in other surgical applications for decades.” Surgical Innovation was founded in 2016 by affiliates of Northwestern University Feinberg School of Medicine and Kellogg School of Business in order to develop and commercialize an alternative to certain problematic, cadaver-derived, biologic implants that are currently used.